Skip to content

13F-HR/A filed by Ghost Tree Capital, LLC

Ghost Tree Capital, LLC filed this 13F-HR/A for the quarter ended 2014-12-31, filed 2015-02-18, with 59 holding rows worth $208,403,000.

Accession
0001140361-15-007632
Filed
2015-02-18
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, amendment of type restatement, 59 entries on the cover page, a total value of $208,403,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $208,403,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Gilead Sciences,Inc.375558103COM125,000$11,783,000thousands by filing datecall
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock86,200$9,777,000thousands by filing date
Stryker Corporation863667101COM100,000$9,433,000thousands by filing datecall
ISIS PHARMACEUTICALS INC464330109COM150,000$9,261,000thousands by filing datecall
AVALANCHE BIOT05337G107Common Stock125,000$6,750,000thousands by filing date
WRIGHT MED GROUP INC98235T107COM235,000$6,314,000thousands by filing date
Gilead Sciences,Inc.375558103COM65,000$6,127,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK30,000$5,678,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON325,000$5,567,000thousands by filing date
CEPHEID15670R107COM100,000$5,414,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock55,000$5,335,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2286,053$5,278,000thousands by filing date
DEPOMED INC249908104COM300,000$4,833,000thousands by filing date
DYAX CORP26746E103COM325,000$4,570,000thousands by filing date
ACTAVIS PLCG0083B108SHS17,500$4,505,000thousands by filing date
ZELTIQ AESTHETICS INC98933Q108COM160,000$4,466,000thousands by filing date
NEVRO CORP64157F103COM115,000$4,447,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM85,000$4,400,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock150,000$4,248,000thousands by filing date
NUVASIVE INC670704105COM90,000$4,244,000thousands by filing date
INSYS THERAPEUTICS INC45824V209COMMON STOCK100,000$4,216,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS300,000$3,867,000thousands by filing date
AIR METHODS CORP009128307COM PAR $.0685,000$3,743,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM40,000$3,616,000thousands by filing date
KITE PHARMA INC49803L109COM60,000$3,460,000thousands by filing date
SALIX PHARMACEUTICALS INC795435106COM30,000$3,448,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM80,000$3,410,000thousands by filing date
ADVAXIS INC007624208COM NEW423,100$3,389,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock30,000$3,338,000thousands by filing date
Stryker Corporation863667101COM35,000$3,302,000thousands by filing date
ISIS PHARMACEUTICALS INC464330109COM50,000$3,087,000thousands by filing dateput
OPHTHOTECH CORP683745103COM65,000$2,917,000thousands by filing date
QUIDEL CORP74838J101COM100,000$2,892,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM20,000$2,862,000thousands by filing date
THERAPEUTICSMD INC88338N107COM636,800$2,834,000thousands by filing date
BLUEBIRD BIO INC09609G100COM30,000$2,752,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM300,000$2,496,000thousands by filing date
ACCURAY INC DEL004397105COM300,000$2,265,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR80,000$2,170,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM4,000$2,116,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM175,000$2,104,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM300,000$2,061,000thousands by filing date
ATRICURE INC04963C209COM100,000$1,996,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM150,000$1,838,000thousands by filing datecall
IMMUNOGEN INC CMN STK45253H901Cmn300,000$1,830,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM75,000$1,728,000thousands by filing date
RAPTOR PHARMACEUTICAL CORP75382F106COM150,000$1,578,000thousands by filing date
MERIT MED SYS INC COM589889104Stock75,000$1,300,000thousands by filing date
Tandem Diabetes Care, Inc.875372104COM100,000$1,270,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM90,000$1,254,000thousands by filing date
SMITH & NEPHEW PLC SPDN ADR NEW83175M205ADR30,000$1,102,000thousands by filing date
AUSPEX PHARMACE05211J102Common Stock20,000$1,050,000thousands by filing date
WRIGHT MED GROUP INC98235T115RIGHT 03/01/2019185,000$884,000thousands by filing date
OCERA THERAPEUTICS INC COM67552A108COM125,000$796,000thousands by filing date
BIOLASE INC090911108COMMON STOCK300,000$789,000thousands by filing date
CELLADON CORP15117E107Cmn40,000$781,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM250,000$743,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM65,000$511,000thousands by filing date
GLOBEIMMUNE INC37957B100COM23,500$178,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-15-006783 superseded2015-02-17acceptance time not in the bulk data set
13F-HR/A 0001140361-15-007632this filing2015-02-18acceptance time not in the bulk data set